|
Aethlon Medical, Inc. (Aethlon Medical) is a medical device company. The company's core development is Aethlon ADAPT, a medical device that converges single or multiple affinity drug agents with advanced plasma membrane technology. Aethlon medical's Hemopurifier device target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. This technology is designed to reduce the presence of infectious viruses and other toxins from human blood. Aethlon Medical focuses on the treatment of cancer and chronic infectious diseases including Hepatitis-C and HIV, diseases caused by drug and vaccine resistant viruses. The company's wholly owned subsidiary is Exosome Sciences, Inc. The company is headquartered in California, the US. ( http://www.companyprofilesandconferences.com/report/Aethlon-Medical-Inc-AEMD-Product-Pipeline-Analysis.html ) This report is a source for data, analysis and actionable intelligence on the Aethlon Medical, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. For more information kindly visit : http://www.companyprofilesandconferences.com/report/Aethlon-Medical-Inc-AEMD-Product-Pipeline-Analysis.html Or Contact us at : Company Profiles and Conferences Flat A-1901/02, 19th floor, Kshitij Building,Sec-19, Palm Beach Road, Sanpada, Navi Mumbai - 400705, India. Phone : +91 22 2756 1536 Fax : +91 22 2757 9131 E-mail : info@companyprofilesandconferences.com Website : www.companyprofilesandconferences.com
Related Articles -
Company Pofiles, Aethlon Medical Inc, AEMD, Company Profile,
|
